QALYs imperfect, but still the NICE choice

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.671, 2013-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of QALYs by UK NICE for IFN- decision inappropriate

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 284, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

NICE revises AD guidance, but pharma still not happy

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 537, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

QALYs and Carers

By Al-Janabi Hareth

PharmacoEconomics, Vol. 29, Iss. 12, 2011-12 ,pp. : 1015-1023

Adis International

Access to resources Recommend Favorite

Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis?

Current Drug Targets, Vol. 12, Iss. 10, 2011-09 ,pp. : 1396-1405

Bentham Science Publishers

Access to resources Recommend Favorite

A Stated Preference Binary Choice Experiment to Explore NICE Decision Making

By Tappenden Paul Brazier John Ratcliffe Julie Chilcott James

PharmacoEconomics, Vol. 25, Iss. 8, 2007-01 ,pp. : 685-693

Adis International

Access to resources Recommend Favorite